EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

Digital Therapeutics for People with Schizophrenia Spectrum Disorders: A Systematic Literature Review of Their Effect on Symptoms and Functioning

Daniel Fulford, Christoph U Correll, Philip D Harvey iD, Alex S Cohen iD

Schizophrenia Bulletin · 03.07.2026 · 52 (4)

DOI: 10.1093/schbul/sbaf134 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Schizophrenia Bulletin, online erschienen am 25.08.2025. Verfasst von Daniel Fulford und 3 weiteren Autor:innen. Beteiligte Einrichtung: Sargent College of Health & Rehabilitation Sciences, Boston University, Boston, MA 02215, United States. Hauptthemen laut MEDLINE: Schizophrenia, Outcome Assessment, Health Care, Quality of Life. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Boehringer Ingelheim Pharmaceuticals, Inc.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Hypothesis Digital therapeutics (DTs; health software to treat/alleviate a disease/condition) may provide accessible evidence-based care to people with schizophrenia spectrum disorders (SSDs). This systematic literature review (SLR) investigated whether people with SSD find DTs acceptable and can use them effectively; whether DTs are effective and generally safe; and if DT use can impact functioning, quality of life (QoL), and other outcomes. Study Design This PROSPERO-registered SLR (CRD42023476545) was conducted to identify articles assessing DTs in adults with SSD. Databases (MEDLINE/Embase/PsycINFO/Cochrane-SR/ClinicalTrials.gov/WHO International Clinical Trials Registry) and key congresses were searched up to January 28, 2024. Screening was completed by 2 reviewers, each blinded to the other’s decisions, and article summaries were extracted. Study Results Of 886 unique citations, 115 eligible citations provided 38 unique primary studies with results and 10 linked citations. Engagement and satisfaction with DTs were generally high. Among 24 studies assessing the effectiveness of DT use on negative and positive symptoms, cognitive performance, mood, depression and/or anxiety, medication adherence, recovery, and general/other symptoms, 17 had ≥1 outcome showing significant change versus comparator/baseline; 24 had ≥1 outcome showing no significant difference. DTs were generally safe. Of 24 studies reporting real-world functioning, QoL, and other outcomes, 11 reported ≥1 significant outcome; 24 reported ≥1 outcome showing no difference versus comparator/baseline. Conclusions People with SSD can use DTs effectively and find them acceptable. Although effectiveness outcomes varied across/within studies, DTs may provide an acceptable strategy for delivering accessible, generally safe, evidence-based care to people with SSD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SchizophreniaOutcome Assessment, Health CareQuality of LifeHumansDigital Health

Stichwörter der Autor:innen

efficacyengagementevidence-based softwarequality of lifereal-world functioningsmartphone app

Autor:innen und Institutionen

  • Sargent College of Health & Rehabilitation Sciences, Boston University, Boston, MA 02215, United States.
  • Department of Psychological & Brain Sciences, Boston University, Boston, MA 02215, United States.
  • Department of Psychiatry and Molecular Medicine, The Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY 11549, United States.
  • Center for Psychiatric Neuroscience, Feinstein Institute for Medical Research, Manhasset, NY 11030, United States.
  • Department of Child and Adolescent Psychiatry, Charité - Universitätsmedizin Berlin, 10117 Berlin, Germany.
  • German Center for Mental Health (DZPG), partner site Berlin, 10117 Berlin, Germany.

ORCID-Profile: Philip D Harvey, Alex S Cohen

Förderung

  • Boehringer Ingelheim Pharmaceuticals, Inc

Zitieren

APA

Fulford, D., Correll, C. U., Harvey, P. D., & Cohen, A. S. (2026). Digital Therapeutics for People with Schizophrenia Spectrum Disorders: A Systematic Literature Review of Their Effect on Symptoms and Functioning. Schizophrenia Bulletin, 52(4). https://doi.org/10.1093/schbul/sbaf134

Vancouver

Fulford D, Correll CU, Harvey PD, Cohen AS. Digital Therapeutics for People with Schizophrenia Spectrum Disorders: A Systematic Literature Review of Their Effect on Symptoms and Functioning. Schizophrenia Bulletin. 2026;52(4). doi:10.1093/schbul/sbaf134

BibTeX
@article{Fulford2026,
  author = {Fulford, Daniel and Correll, Christoph U and Harvey, Philip D and Cohen, Alex S},
  title = {Digital Therapeutics for People with Schizophrenia Spectrum Disorders: A Systematic Literature Review of Their Effect on Symptoms and Functioning},
  journal = {Schizophrenia Bulletin},
  year = {2026},
  volume = {52},
  number = {4},
  doi = {10.1093/schbul/sbaf134}
}
Kostenlos starten →